NO333481B1 - 7-(4-substituert-3-cyklopropylaminometyl-1-pyrrolidinyl)kinolonkarboksylsyrederivater, samt antibakterielt middel inneholdende samme - Google Patents

7-(4-substituert-3-cyklopropylaminometyl-1-pyrrolidinyl)kinolonkarboksylsyrederivater, samt antibakterielt middel inneholdende samme Download PDF

Info

Publication number
NO333481B1
NO333481B1 NO20061050A NO20061050A NO333481B1 NO 333481 B1 NO333481 B1 NO 333481B1 NO 20061050 A NO20061050 A NO 20061050A NO 20061050 A NO20061050 A NO 20061050A NO 333481 B1 NO333481 B1 NO 333481B1
Authority
NO
Norway
Prior art keywords
fluoro
group
cyclopropylaminomethyl
dihydro
oxo
Prior art date
Application number
NO20061050A
Other languages
English (en)
Norwegian (no)
Other versions
NO20061050L (no
Inventor
Yoshikazu Asahina
Masaya Takei
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of NO20061050L publication Critical patent/NO20061050L/no
Publication of NO333481B1 publication Critical patent/NO333481B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20061050A 2003-09-10 2006-03-03 7-(4-substituert-3-cyklopropylaminometyl-1-pyrrolidinyl)kinolonkarboksylsyrederivater, samt antibakterielt middel inneholdende samme NO333481B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003318897 2003-09-10
PCT/JP2004/013049 WO2005026147A1 (ja) 2003-09-10 2004-09-08 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体

Publications (2)

Publication Number Publication Date
NO20061050L NO20061050L (no) 2006-04-04
NO333481B1 true NO333481B1 (no) 2013-06-24

Family

ID=34308537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061050A NO333481B1 (no) 2003-09-10 2006-03-03 7-(4-substituert-3-cyklopropylaminometyl-1-pyrrolidinyl)kinolonkarboksylsyrederivater, samt antibakterielt middel inneholdende samme

Country Status (18)

Country Link
US (2) US7514451B2 (de)
EP (1) EP1666477B1 (de)
JP (1) JP4639149B2 (de)
KR (1) KR101077755B1 (de)
CN (1) CN100410249C (de)
AU (1) AU2004272414B2 (de)
BR (1) BRPI0413964B8 (de)
CA (1) CA2536429C (de)
CY (1) CY1114476T1 (de)
DK (1) DK1666477T3 (de)
ES (1) ES2424676T3 (de)
NO (1) NO333481B1 (de)
NZ (1) NZ545472A (de)
PL (1) PL1666477T3 (de)
PT (1) PT1666477E (de)
SG (1) SG144936A1 (de)
SI (1) SI1666477T1 (de)
WO (1) WO2005026147A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666477B1 (de) * 2003-09-10 2013-07-03 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituiertes 3-cyclopropylaminomethyl-1-pyrrolidinyl)chinoloncarbonsäurederivat
EP1992613B1 (de) 2006-03-09 2013-01-30 Kyorin Pharmaceutical Co., Ltd. Verfahren zur herstellung von 3,4-disubstituiertem pyrrolidinderivat und zwischenprodukt für die herstellung
CN103038212B (zh) * 2010-05-31 2015-04-22 杏林制药株式会社 3-取代-4-氟吡咯烷衍生物的制造方法
CN103228628B (zh) 2010-10-25 2016-06-29 杏林制药株式会社 制备3,4-双取代的吡咯烷衍生物的方法
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
WO2013145749A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
EP2990039A4 (de) * 2013-04-25 2017-02-22 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
WO2014174846A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
WO2014174848A1 (ja) * 2013-04-25 2014-10-30 杏林製薬株式会社 錠剤
JP6018334B2 (ja) * 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物
KR102532681B1 (ko) * 2015-03-13 2023-05-15 교린 세이야꾸 가부시키 가이샤 호흡기 감염증 치료제
JP6031217B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
WO2016195020A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
EP3305296A4 (de) * 2015-06-02 2019-02-13 Kyorin Pharmaceutical Co., Ltd. Wässrige flüssige formulierung
EP3305294A4 (de) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. Wässriges arzneimittel
JP6031216B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
CN106831795B (zh) * 2017-01-16 2018-12-21 石家庄学院 喹诺酮异土木香内酯衍生物及其制备和应用
CN116549446A (zh) 2017-06-16 2023-08-08 杏林制药株式会社 吸入性肺炎、肺化脓或肺脓肿的治疗剂
KR20200016960A (ko) 2017-06-16 2020-02-17 교린 세이야꾸 가부시키 가이샤 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292317A (en) 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
SE440354B (sv) 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US5281612A (en) 1982-09-09 1994-01-25 Warner-Lambert Company Naphthyridine antibacterial agents
US4665079A (en) 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4638067A (en) 1982-09-09 1987-01-20 Warner-Lambert Co. Antibacterial agents
US4777175A (en) 1982-09-09 1988-10-11 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4822801A (en) 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4604401A (en) 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
US5097032A (en) 1984-07-20 1992-03-17 Warner-Lambert Company Antibacterial agents - II
US4771054A (en) 1985-01-23 1988-09-13 Warner-Lambert Company Antibacterial agents
AU578793B2 (en) * 1985-02-15 1988-11-03 Dainippon Pharmaceutical Co. Ltd. Novel 1,8-naphthyridine derivatives and processes for preparation thereof
JPS61282362A (ja) 1985-06-07 1986-12-12 バイエル・アクチエンゲゼルシヤフト キノロンカルボン酸エステル
ATE75740T1 (de) 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
JPH0635457B2 (ja) 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
JPH0696572B2 (ja) 1985-07-17 1994-11-30 大日本製薬株式会社 ピリドンカルボン酸誘導体、そのエステルおよびその塩
DE3617803A1 (de) 1985-11-07 1987-11-19 Bayer Ag Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen
JPH0633256B2 (ja) * 1985-12-20 1994-05-02 大塚製薬株式会社 キノリンカルボン酸誘導体
JPS62228063A (ja) 1985-12-27 1987-10-06 Sankyo Co Ltd キノリンカルボン酸誘導体
JPS62215572A (ja) 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPS63198664A (ja) 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (de) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Chinolinderivate und Verfahren zu ihrer Herstellung
US4771055A (en) 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
DE3632222A1 (de) 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
US4965273A (en) 1986-10-08 1990-10-23 Bristol-Myers Company Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
US4954507A (en) 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3641312A1 (de) 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JPH0723369B2 (ja) 1986-12-27 1995-03-15 第一製薬株式会社 ピリドンカルボン酸誘導体
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
DE3711193A1 (de) 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5290934A (en) 1987-04-16 1994-03-01 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5563138A (en) 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
DE3719764A1 (de) 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
JP2598929B2 (ja) 1987-11-19 1997-04-09 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
US5173484A (en) 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
DE3814517A1 (de) 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5336768A (en) 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
DE3902079A1 (de) 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
JP2844079B2 (ja) 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
US5262417A (en) 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5407932A (en) 1989-03-31 1995-04-18 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and antibacterial agents containing the same
JPH03188074A (ja) * 1989-03-31 1991-08-16 Wakunaga Pharmaceut Co Ltd 新規キノロン誘導体及びこれを含有する抗菌剤
CA2012681A1 (en) 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
US5252734A (en) 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3910663A1 (de) 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5266569A (en) 1989-08-16 1993-11-30 Pfizer Inc. Azatricyclo carboxylic acids useful as anti-bacterial agents
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
DE4123918A1 (de) 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
US5468742A (en) 1991-07-19 1995-11-21 Bayer Aktiengesellschaft 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
JP3209367B2 (ja) 1992-08-25 2001-09-17 セイコー化成株式会社 透湿性防水布帛の製造方法
US5646163A (en) 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CA2152828A1 (en) 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
CA2175351A1 (en) 1993-10-28 1995-05-04 Jun Nakano Quinolinecarboxylic acid derivative and salt thereof
DE4408212A1 (de) 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
DE69524251T2 (de) * 1994-06-14 2002-07-11 Dainippon Pharmaceutical Co Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
WO1996033992A1 (fr) * 1995-04-27 1996-10-31 Kaken Pharmaceutical Co., Ltd. Derives d'acide quinolinecarboxylique optiquement actifs et sels de ces derives
ID16655A (id) * 1996-04-24 1997-10-30 Daiichi Seiyaku Co Turunan-turunan sikloalkilaminometilpirolidina
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
WO1999014214A1 (en) 1997-09-15 1999-03-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6740664B2 (en) 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6440964B1 (en) 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
JP2000319261A (ja) 1999-05-13 2000-11-21 Dai Ichi Seiyaku Co Ltd キノロンカルボン酸類の製造方法
SE9904108D0 (sv) 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
CN1312131C (zh) 2000-02-09 2007-04-25 第一制药株式会社 包含作为活性成分的吡啶酮羧酸的抗耐酸细菌药
US6699989B1 (en) 2000-08-28 2004-03-02 B. Vithal Shetty Antiviral and antimicrobial guanidine or biguanidine derivatives
DE60329280D1 (de) * 2002-03-18 2009-10-29 Kyorin Seiyaku Kk 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien
EP1666477B1 (de) * 2003-09-10 2013-07-03 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituiertes 3-cyclopropylaminomethyl-1-pyrrolidinyl)chinoloncarbonsäurederivat
WO2005049602A1 (en) 2003-11-18 2005-06-02 Warner-Lambert Company Llc Quinolone antibacterial agents
WO2005070941A1 (en) 2004-01-13 2005-08-04 Cumbre Pharmaceuticals Inc. Rifamycin imino derivatives effective against drug-resistant microbes
CN1273452C (zh) 2004-06-01 2006-09-06 中国医学科学院医药生物技术研究所 7-(4,4-二甲基-3-氨甲基吡咯烷-1-基)取代的新喹啉羧酸衍生物及其制法
CN1861599A (zh) 2005-05-11 2006-11-15 孙飘扬 喹诺酮羧酸类衍生物及其制备方法和药物用途
WO2008021491A2 (en) 2006-08-16 2008-02-21 Achillion Pharmaceuticals, Inc. Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones

Also Published As

Publication number Publication date
BRPI0413964A (pt) 2006-10-31
US8106072B2 (en) 2012-01-31
JPWO2005026147A1 (ja) 2007-11-08
CY1114476T1 (el) 2016-10-05
AU2004272414B2 (en) 2009-05-28
CA2536429A1 (en) 2005-03-24
SI1666477T1 (sl) 2013-10-30
AU2004272414A1 (en) 2005-03-24
SG144936A1 (en) 2008-08-28
NO20061050L (no) 2006-04-04
BRPI0413964B1 (pt) 2017-03-28
DK1666477T3 (da) 2013-07-29
KR20060123096A (ko) 2006-12-01
EP1666477B1 (de) 2013-07-03
ES2424676T3 (es) 2013-10-07
JP4639149B2 (ja) 2011-02-23
NZ545472A (en) 2009-09-25
EP1666477A4 (de) 2008-10-22
WO2005026147A1 (ja) 2005-03-24
US7514451B2 (en) 2009-04-07
CN1849316A (zh) 2006-10-18
KR101077755B1 (ko) 2011-10-27
US20090176824A1 (en) 2009-07-09
US20060281779A1 (en) 2006-12-14
PL1666477T3 (pl) 2013-11-29
CN100410249C (zh) 2008-08-13
BRPI0413964B8 (pt) 2021-05-25
PT1666477E (pt) 2013-08-28
CA2536429C (en) 2012-02-14
EP1666477A1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
NO333481B1 (no) 7-(4-substituert-3-cyklopropylaminometyl-1-pyrrolidinyl)kinolonkarboksylsyrederivater, samt antibakterielt middel inneholdende samme
JP4111431B2 (ja) キノロン−およびナフチリドン−カルボン酸誘導体類
AU3048389A (en) Antibacterial agents
NO175939B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv N1-(1,2-cis-2-halogencyklopropyl)-substituerte pyridonkarboksylsyrederivater, eller et farmasöytisk akseptabelt salt derav, eventuelt i en stereoisomerisk form
RU2111964C1 (ru) Производные 7-изоиндолинилхинолона и 7-изоиндолинилнафтиридона
US5633264A (en) Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-Quinolones and naphthyridones as antibacterial agents
JPH0635457B2 (ja) ピリドンカルボン酸誘導体およびその製造方法
EP0787720B1 (de) Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
MXPA04009026A (es) Derivados de acido 10- (3- ciclopropilaminometil -1-pirrolidinil) piridobenzoxazin- carboxilico efectivos contra bacterias resistentes a farmacos.
EP0947513B1 (de) Tricyclische aminderivate
JP3794737B2 (ja) キノロン−及びナフチリドンカルボン酸誘導体
IE62205B1 (en) Individual stereoisomers of 7-(3-(1-aminoalkyl)-1-pyrrolidinyl)-quinolones and naphthyridones as antibacterial agents
AU726378B2 (en) Cycloalkylaminomethylpyrrolidine derivatives
MXPA06002817A (en) 7-(4-substituted 3- cyclopropylaminomethyl-1 - pyrrolidinyl) quinolonecarboxylic acid derivative
KR100219327B1 (ko) 퀴놀론 카르복실산 유도체
RU2105770C1 (ru) Производные хинолон- и нафтиридонкарбоновой кислоты в виде смеси изомеров или отдельных изомеров, их гидраты и соли, фармацевтическая композиция
JPH037260A (ja) 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤
JP3951136B2 (ja) 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤
JP4009874B2 (ja) 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees